You are here: Home » News-CM » Companies » News
Business Standard

Vista Pharmaceuticals gets USFDA warning letter

Capital Market 

In response to its detailed reply submitted in October 2016

announced that the Company has been issued a warning letter by the United States Food and Drug Administration (USFDA), in response to its detailed reply submitted in October 2016. The Company will respond with complete details of remedial action to USFDA before the stipulated date.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, July 13 2017. 15:55 IST
RECOMMENDED FOR YOU